These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2109038)

  • 1. Purification of macrophage deactivating factor.
    Srimal S; Nathan C
    J Exp Med; 1990 Apr; 171(4):1347-61. PubMed ID: 2109038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transforming growth factor-beta and a macrophage- deactivating polypeptide from tumor cells. Differences in antigenicity and mechanism of action.
    Tsunawaki S; Sporn M; Nathan C
    J Immunol; 1989 May; 142(10):3462-8. PubMed ID: 2715632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.
    Ding A; Nathan CF; Graycar J; Derynck R; Stuehr DJ; Srimal S
    J Immunol; 1990 Aug; 145(3):940-4. PubMed ID: 2115549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards large-scale purification of natural CSF-1 from human placenta tissue extracts.
    Martin-Thouvenin V; Uhlrich S; Tayot JL; Lanotte M
    Biotechnol Appl Biochem; 1990 Apr; 12(2):176-87. PubMed ID: 2184839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of macrophage activity by mitogen-induced goldfish leukocyte deactivating factor.
    Stafford J; Neumann NF; Belosevic M
    Dev Comp Immunol; 1999; 23(7-8):585-96. PubMed ID: 10579387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage deactivation. Altered kinetic properties of superoxide-producing enzyme after exposure to tumor cell-conditioned medium.
    Tsunawaki S; Nathan CF
    J Exp Med; 1986 Oct; 164(4):1319-31. PubMed ID: 3020151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte-deactivating factor from macrophages: partial purification and biochemical characterization. A novel cytokine.
    Camarero VC; Colepicolo P; Ribeiro JM; Karnovsky ML
    J Cell Physiol; 1993 Oct; 157(1):84-9. PubMed ID: 8408245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the lipophilic factor produced by macrophages that stimulates steroidogenesis.
    Nes WD; Lukyanenko YO; Jia ZH; Quideau S; Howald WN; Pratum TK; West RR; Hutson JC
    Endocrinology; 2000 Mar; 141(3):953-8. PubMed ID: 10698170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterisation of soluble tumour haemolytic factor isolated from oncogene transformed fibroblasts.
    Zucker S; Wieman J; Lysik RM; Imhof B; Farooqui AA
    Br J Cancer; 1990 Jul; 62(1):28-32. PubMed ID: 2202421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1.
    Nordan RP; Pumphrey JG; Rudikoff S
    J Immunol; 1987 Aug; 139(3):813-7. PubMed ID: 3496392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical analysis and biological activities of immunoaffinity purified natural murine gamma interferon (MuIFN-gamma).
    Greenfield RS; Kiener PA; Chin DP; Curry RC; Spitalny GL
    J Leukoc Biol; 1986 Dec; 40(6):665-76. PubMed ID: 3097224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of biologically active scatter factor from ras-transformed NIH 3T3 conditioned medium.
    Coffer A; Fellows J; Young S; Pappin D; Rahman D
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):35-41. PubMed ID: 1831975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte/macrophage colony-stimulating factor from mouse lung conditioned medium. Purification of multiple forms and radioiodination.
    Burgess AW; Metcalf D; Sparrow LG; Simpson RJ; Nice EC
    Biochem J; 1986 May; 235(3):805-14. PubMed ID: 3489462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.
    Reed SG; Nathan CF; Pihl DL; Rodricks P; Shanebeck K; Conlon PJ; Grabstein KH
    J Exp Med; 1987 Dec; 166(6):1734-46. PubMed ID: 3119762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A macrophage differentiating factor derived from human T cell line HUT102 acting on a mouse myeloid cell line M1.
    Kanno H; Nose M; Niki T; Miyazawa M; Kyogoku M
    Tohoku J Exp Med; 1993 Sep; 171(1):43-52. PubMed ID: 8129828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of a cytotoxic factor produced by a mouse macrophage hybridoma.
    Takeda Y; Shimada S; Sugimoto M; Woo HJ; Higuchi M; Osawa T
    Cell Immunol; 1985 Dec; 96(2):277-89. PubMed ID: 3837693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein.
    Stuehr DJ; Cho HJ; Kwon NS; Weise MF; Nathan CF
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7773-7. PubMed ID: 1715579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of hemopoietic cells.
    Clark-Lewis I; Kent SB; Schrader JW
    J Biol Chem; 1984 Jun; 259(12):7488-94. PubMed ID: 6429132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and purification of a macrophage-triggering factor produced in Mycoplasma arginini-infected L5178Y cell cultures.
    Yang G; Coffman FD; Wheelock EF
    J Immunol; 1994 Sep; 153(6):2579-91. PubMed ID: 8077668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and N-terminal amino acid sequence of the Ah receptor from the C57BL/6J mouse.
    Bradfield CA; Glover E; Poland A
    Mol Pharmacol; 1991 Jan; 39(1):13-9. PubMed ID: 1846217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.